ノバルティスのインスタグラム(novartis) - 7月2日 21時55分

“Patient associations are becoming more and more active as regards real-world evidence. They use data collections to learn about the impact of diseases on patients and share these insights with many stakeholders, including pharma. If we work with patient associations and listen to them, and if we really pick up on what matters most to them, we can make a big difference in clinical development.” #HowWeSeeIt #WorkingWithPatients
.
.
Michael Seewald
Head Real World Evidence and Digital,
Novartis

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する